These updates include more explicit warnings about gastrointestinal side effects, gallbladder issues, potential vision loss, and other adverse events, aiming to enhance transparency and patient awareness
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
Atrium Medical does not sell unverified gray-market injections, unbranded house blends, research-use products, or medication mixes marketed as cheaper substitutes for approved GLP-1 medications
These include detection of residual gastric contents, prokinetic agents, modification of anaesthesia, or deferral of procedure (see figure and explanatory notes)
All under the guidance of a clinician who determines eligibility. Because of the changing market and increasing demand, Weight Watchers Clinic now offers compounded semaglutide: In October (2024), we introduced compounded semaglutide into its offering, broadening eligible members access to clinical weight management interventions